Pac Premier
Giving Guide
You are here:  Home  >  Biotech  >  Current Article

Thousand Oaks biotech Amgen ponders acquisitions

By   /   Friday, February 7th, 2020  /   Comments Off on Thousand Oaks biotech Amgen ponders acquisitions

    Print       Email
Amgen entered 2020 with a conservative financial outlook, but that did nothing to dampen expectations for continued acquisitions. The company reported declines in sales and net income in 2019, but results beat analyst estimates, and shares recovered from a brief slump in the first days of February. Its guidance for fiscal 2020 fell short of…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Limoneira, Calavo both report earnings growth as produce industry continues recovery

Read More →